Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Recombinant Proteins Revenue 1.4 Market Analysis by Type 1.4.1 Global Recombinant Proteins Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Hormones 1.4.3 Growth Factors 1.4.4 Cytokines 1.4.5 Plasma Protein Factor 1.4.6 Recombinant Metabolic Enzymes 1.4.7 Immune Checkpoint Regulators 1.4.8 Others 1.5 Market by Application 1.5.1 Global Recombinant Proteins Market Share by Application: 2020 VS 2026 1.5.2 Biopharmaceutical Companies 1.5.3 Academic and Research Institutes 1.5.4 Contract Research Organizations 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Recombinant Proteins Market Perspective (2015-2026) 2.2 Recombinant Proteins Growth Trends by Regions 2.2.1 Recombinant Proteins Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Recombinant Proteins Historic Market Share by Regions (2015-2020) 2.2.3 Recombinant Proteins Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Recombinant Proteins Market Growth Strategy 2.3.6 Primary Interviews with Key Recombinant Proteins Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Recombinant Proteins Players by Market Size 3.1.1 Global Top Recombinant Proteins Players by Revenue (2015-2020) 3.1.2 Global Recombinant Proteins Revenue Market Share by Players (2015-2020) 3.1.3 Global Recombinant Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Recombinant Proteins Market Concentration Ratio 3.2.1 Global Recombinant Proteins Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Recombinant Proteins Revenue in 2019 3.3 Recombinant Proteins Key Players Head office and Area Served 3.4 Key Players Recombinant Proteins Product Solution and Service 3.5 Date of Enter into Recombinant Proteins Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Recombinant Proteins Historic Market Size by Type (2015-2020) 4.2 Global Recombinant Proteins Forecasted Market Size by Type (2021-2026) 5 Recombinant Proteins Breakdown Data by Application (2015-2026) 5.1 Global Recombinant Proteins Market Size by Application (2015-2020) 5.2 Global Recombinant Proteins Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Recombinant Proteins Market Size (2015-2020) 6.2 Recombinant Proteins Key Players in North America (2019-2020) 6.3 North America Recombinant Proteins Market Size by Type (2015-2020) 6.4 North America Recombinant Proteins Market Size by Application (2015-2020) 7 Europe 7.1 Europe Recombinant Proteins Market Size (2015-2020) 7.2 Recombinant Proteins Key Players in Europe (2019-2020) 7.3 Europe Recombinant Proteins Market Size by Type (2015-2020) 7.4 Europe Recombinant Proteins Market Size by Application (2015-2020) 8 China 8.1 China Recombinant Proteins Market Size (2015-2020) 8.2 Recombinant Proteins Key Players in China (2019-2020) 8.3 China Recombinant Proteins Market Size by Type (2015-2020) 8.4 China Recombinant Proteins Market Size by Application (2015-2020) 9 Japan 9.1 Japan Recombinant Proteins Market Size (2015-2020) 9.2 Recombinant Proteins Key Players in Japan (2019-2020) 9.3 Japan Recombinant Proteins Market Size by Type (2015-2020) 9.4 Japan Recombinant Proteins Market Size by Application (2015-2020) 10 Middle East 10.1 Middle East Recombinant Proteins Market Size (2015-2020) 10.2 Recombinant Proteins Key Players in Middle East (2019-2020) 10.3 Middle East Recombinant Proteins Market Size by Type (2015-2020) 10.4 Middle East Recombinant Proteins Market Size by Application (2015-2020) 11 India 11.1 India Recombinant Proteins Market Size (2015-2020) 11.2 Recombinant Proteins Key Players in India (2019-2020) 11.3 India Recombinant Proteins Market Size by Type (2015-2020) 11.4 India Recombinant Proteins Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Recombinant Proteins Market Size (2015-2020) 12.2 Recombinant Proteins Key Players in Central & South America (2019-2020) 12.3 Central & South America Recombinant Proteins Market Size by Type (2015-2020) 12.4 Central & South America Recombinant Proteins Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Abcam PLC 13.1.1 Abcam PLC Company Details 13.1.2 Abcam PLC Business Overview and Its Total Revenue 13.1.3 Abcam PLC Recombinant Proteins Introduction 13.1.4 Abcam PLC Revenue in Recombinant Proteins Business (2015-2020)) 13.1.5 Abcam PLC Recent Development 13.2 R&D Systems 13.2.1 R&D Systems Company Details 13.2.2 R&D Systems Business Overview and Its Total Revenue 13.2.3 R&D Systems Recombinant Proteins Introduction 13.2.4 R&D Systems Revenue in Recombinant Proteins Business (2015-2020) 13.2.5 R&D Systems Recent Development 13.3 Miltenyi Biotec 13.3.1 Miltenyi Biotec Company Details 13.3.2 Miltenyi Biotec Business Overview and Its Total Revenue 13.3.3 Miltenyi Biotec Recombinant Proteins Introduction 13.3.4 Miltenyi Biotec Revenue in Recombinant Proteins Business (2015-2020) 13.3.5 Miltenyi Biotec Recent Development 13.4 Thermo Fisher Scientific 13.4.1 Thermo Fisher Scientific Company Details 13.4.2 Thermo Fisher Scientific Business Overview and Its Total Revenue 13.4.3 Thermo Fisher Scientific Recombinant Proteins Introduction 13.4.4 Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2015-2020) 13.4.5 Thermo Fisher Scientific Recent Development 13.5 Sigma Aldrich Company 13.5.1 Sigma Aldrich Company Company Details 13.5.2 Sigma Aldrich Company Business Overview and Its Total Revenue 13.5.3 Sigma Aldrich Company Recombinant Proteins Introduction 13.5.4 Sigma Aldrich Company Revenue in Recombinant Proteins Business (2015-2020) 13.5.5 Sigma Aldrich Company Recent Development 13.6 GE Healthcare 13.6.1 GE Healthcare Company Details 13.6.2 GE Healthcare Business Overview and Its Total Revenue 13.6.3 GE Healthcare Recombinant Proteins Introduction 13.6.4 GE Healthcare Revenue in Recombinant Proteins Business (2015-2020) 13.6.5 GE Healthcare Recent Development 13.7 Lonza 13.7.1 Lonza Company Details 13.7.2 Lonza Business Overview and Its Total Revenue 13.7.3 Lonza Recombinant Proteins Introduction 13.7.4 Lonza Revenue in Recombinant Proteins Business (2015-2020) 13.7.5 Lonza Recent Development 13.8 Merck KGaA 13.8.1 Merck KGaA Company Details 13.8.2 Merck KGaA Business Overview and Its Total Revenue 13.8.3 Merck KGaA Recombinant Proteins Introduction 13.8.4 Merck KGaA Revenue in Recombinant Proteins Business (2015-2020) 13.8.5 Merck KGaA Recent Development 13.9 ProSpec Tany TechnoGene 13.9.1 ProSpec Tany TechnoGene Company Details 13.9.2 ProSpec Tany TechnoGene Business Overview and Its Total Revenue 13.9.3 ProSpec Tany TechnoGene Recombinant Proteins Introduction 13.9.4 ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2015-2020) 13.9.5 ProSpec Tany TechnoGene Recent Development 13.10 Eurogentec (Kaneka Corporation) 13.10.1 Eurogentec (Kaneka Corporation) Company Details 13.10.2 Eurogentec (Kaneka Corporation) Business Overview and Its Total Revenue 13.10.3 Eurogentec (Kaneka Corporation) Recombinant Proteins Introduction 13.10.4 Eurogentec (Kaneka Corporation) Revenue in Recombinant Proteins Business (2015-2020) 13.10.5 Eurogentec (Kaneka Corporation) Recent Development 13.11 PeproTech 10.11.1 PeproTech Company Details 10.11.2 PeproTech Business Overview and Its Total Revenue 10.11.3 PeproTech Recombinant Proteins Introduction 10.11.4 PeproTech Revenue in Recombinant Proteins Business (2015-2020) 10.11.5 PeproTech Recent Development 13.12 BPS Bioscience 10.12.1 BPS Bioscience Company Details 10.12.2 BPS Bioscience Business Overview and Its Total Revenue 10.12.3 BPS Bioscience Recombinant Proteins Introduction 10.12.4 BPS Bioscience Revenue in Recombinant Proteins Business (2015-2020) 10.12.5 BPS Bioscience Recent Development 13.13 Reprocell 10.13.1 Reprocell Company Details 10.13.2 Reprocell Business Overview and Its Total Revenue 10.13.3 Reprocell Recombinant Proteins Introduction 10.13.4 Reprocell Revenue in Recombinant Proteins Business (2015-2020) 10.13.5 Reprocell Recent Development 13.14 GenScript Biotech Corporation 10.14.1 GenScript Biotech Corporation Company Details 10.14.2 GenScript Biotech Corporation Business Overview and Its Total Revenue 10.14.3 GenScript Biotech Corporation Recombinant Proteins Introduction 10.14.4 GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2015-2020) 10.14.5 GenScript Biotech Corporation Recent Development 13.15 Abnova Corporation 10.15.1 Abnova Corporation Company Details 10.15.2 Abnova Corporation Business Overview and Its Total Revenue 10.15.3 Abnova Corporation Recombinant Proteins Introduction 10.15.4 Abnova Corporation Revenue in Recombinant Proteins Business (2015-2020) 10.15.5 Abnova Corporation Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Recombinant Proteins Key Market Segments Table 2. Key Players Covered: Ranking by Recombinant Proteins Revenue Table 3. Ranking of Global Top Recombinant Proteins Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Recombinant Proteins Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Hormones Table 6. Key Players of Growth Factors Table 7. Key Players of Cytokines Table 8. Key Players of Plasma Protein Factor Table 9. Key Players of Recombinant Metabolic Enzymes Table 10. Key Players of Immune Checkpoint Regulators Table 11. Key Players of Others Table 12. Global Recombinant Proteins Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Recombinant Proteins Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Recombinant Proteins Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Recombinant Proteins Market Share by Regions (2015-2020) Table 16. Global Recombinant Proteins Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Recombinant Proteins Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Recombinant Proteins Market Growth Strategy Table 22. Main Points Interviewed from Key Recombinant Proteins Players Table 23. Global Recombinant Proteins Revenue by Players (2015-2020) (Million US$) Table 24. Global Recombinant Proteins Market Share by Players (2015-2020) Table 25. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Proteins as of 2019) Table 26. Global Recombinant Proteins by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Recombinant Proteins Product Solution and Service Table 29. Date of Enter into Recombinant Proteins Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Recombinant Proteins Market Size by Type (2015-2020) (Million US$) Table 32. Global Recombinant Proteins Market Size Share by Type (2015-2020) Table 33. Global Recombinant Proteins Revenue Market Share by Type (2021-2026) Table 34. Global Recombinant Proteins Market Size Share by Application (2015-2020) Table 35. Global Recombinant Proteins Market Size by Application (2015-2020) (Million US$) Table 36. Global Recombinant Proteins Market Size Share by Application (2021-2026) Table 37. North America Key Players Recombinant Proteins Revenue (2019-2020) (Million US$) Table 38. North America Key Players Recombinant Proteins Market Share (2019-2020) Table 39. North America Recombinant Proteins Market Size by Type (2015-2020) (Million US$) Table 40. North America Recombinant Proteins Market Share by Type (2015-2020) Table 41. North America Recombinant Proteins Market Size by Application (2015-2020) (Million US$) Table 42. North America Recombinant Proteins Market Share by Application (2015-2020) Table 43. Europe Key Players Recombinant Proteins Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Recombinant Proteins Market Share (2019-2020) Table 45. Europe Recombinant Proteins Market Size by Type (2015-2020) (Million US$) Table 46. Europe Recombinant Proteins Market Share by Type (2015-2020) Table 47. Europe Recombinant Proteins Market Size by Application (2015-2020) (Million US$) Table 48. Europe Recombinant Proteins Market Share by Application (2015-2020) Table 49. China Key Players Recombinant Proteins Revenue (2019-2020) (Million US$) Table 50. China Key Players Recombinant Proteins Market Share (2019-2020) Table 51. China Recombinant Proteins Market Size by Type (2015-2020) (Million US$) Table 52. China Recombinant Proteins Market Share by Type (2015-2020) Table 53. China Recombinant Proteins Market Size by Application (2015-2020) (Million US$) Table 54. China Recombinant Proteins Market Share by Application (2015-2020) Table 55. Japan Key Players Recombinant Proteins Revenue (2019-2020) (Million US$) Table 56. Japan Key Players Recombinant Proteins Market Share (2019-2020) Table 57. Japan Recombinant Proteins Market Size by Type (2015-2020) (Million US$) Table 58. Japan Recombinant Proteins Market Share by Type (2015-2020) Table 59. Japan Recombinant Proteins Market Size by Application (2015-2020) (Million US$) Table 60. Japan Recombinant Proteins Market Share by Application (2015-2020) Table 61. Middle East Key Players Recombinant Proteins Revenue (2019-2020) (Million US$) Table 62. Middle East Key Players Recombinant Proteins Market Share (2019-2020) Table 63. Middle East Recombinant Proteins Market Size by Type (2015-2020) (Million US$) Table 64. Middle East Recombinant Proteins Market Share by Type (2015-2020) Table 65. Middle East Recombinant Proteins Market Size by Application (2015-2020) (Million US$) Table 66. Middle East Recombinant Proteins Market Share by Application (2015-2020) Table 67. India Key Players Recombinant Proteins Revenue (2019-2020) (Million US$) Table 68. India Key Players Recombinant Proteins Market Share (2019-2020) Table 69. India Recombinant Proteins Market Size by Type (2015-2020) (Million US$) Table 70. India Recombinant Proteins Market Share by Type (2015-2020) Table 71. India Recombinant Proteins Market Size by Application (2015-2020) (Million US$) Table 72. India Recombinant Proteins Market Share by Application (2015-2020) Table 73. Central & South America Key Players Recombinant Proteins Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players Recombinant Proteins Market Share (2019-2020) Table 75. Central & South America Recombinant Proteins Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America Recombinant Proteins Market Share by Type (2015-2020) Table 77. Central & South America Recombinant Proteins Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America Recombinant Proteins Market Share by Application (2015-2020) Table 79. Abcam PLC Company Details Table 80. Abcam PLC Business Overview Table 81. Abcam PLC Product Table 82. Abcam PLC Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 83. Abcam PLC Recent Development Table 84. R&D Systems Company Details Table 85. R&D Systems Business Overview Table 86. R&D Systems Product Table 87. R&D Systems Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 88. R&D Systems Recent Development Table 89. Miltenyi Biotec Company Details Table 90. Miltenyi Biotec Business Overview Table 91. Miltenyi Biotec Product Table 92. Miltenyi Biotec Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 93. Miltenyi Biotec Recent Development Table 94. Thermo Fisher Scientific Company Details Table 95. Thermo Fisher Scientific Business Overview Table 96. Thermo Fisher Scientific Product Table 97. Thermo Fisher Scientific Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 98. Thermo Fisher Scientific Recent Development Table 99. Sigma Aldrich Company Company Details Table 100. Sigma Aldrich Company Business Overview Table 101. Sigma Aldrich Company Product Table 102. Sigma Aldrich Company Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 103. Sigma Aldrich Company Recent Development Table 104. GE Healthcare Company Details Table 105. GE Healthcare Business Overview Table 106. GE Healthcare Product Table 107. GE Healthcare Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 108. GE Healthcare Recent Development Table 109. Lonza Company Details Table 110. Lonza Business Overview Table 111. Lonza Product Table 112. Lonza Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 113. Lonza Recent Development Table 114. Merck KGaA Business Overview Table 115. Merck KGaA Product Table 116. Merck KGaA Company Details Table 117. Merck KGaA Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 118. Merck KGaA Recent Development Table 119. ProSpec Tany TechnoGene Company Details Table 120. ProSpec Tany TechnoGene Business Overview Table 121. ProSpec Tany TechnoGene Product Table 122. ProSpec Tany TechnoGene Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 123. ProSpec Tany TechnoGene Recent Development Table 124. Eurogentec (Kaneka Corporation) Company Details Table 125. Eurogentec (Kaneka Corporation) Business Overview Table 126. Eurogentec (Kaneka Corporation) Product Table 127. Eurogentec (Kaneka Corporation) Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 128. Eurogentec (Kaneka Corporation) Recent Development Table 129. PeproTech Company Details Table 130. PeproTech Business Overview Table 131. PeproTech Product Table 132. PeproTech Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 133. PeproTech Recent Development Table 134. BPS Bioscience Company Details Table 135. BPS Bioscience Business Overview Table 136. BPS Bioscience Product Table 137. BPS Bioscience Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 138. BPS Bioscience Recent Development Table 139. Reprocell Company Details Table 140. Reprocell Business Overview Table 141. Reprocell Product Table 142. Reprocell Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 143. Reprocell Recent Development Table 144. GenScript Biotech Corporation Company Details Table 145. GenScript Biotech Corporation Business Overview Table 146. GenScript Biotech Corporation Product Table 147. GenScript Biotech Corporation Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 148. GenScript Biotech Corporation Recent Development Table 149. Abnova Corporation Company Details Table 150. Abnova Corporation Business Overview Table 151. Abnova Corporation Product Table 152. Abnova Corporation Revenue in Recombinant Proteins Business (2015-2020) (Million US$) Table 153. Abnova Corporation Recent Development Table 154. Research Programs/Design for This Report Table 155. Key Data Information from Secondary Sources Table 156. Key Data Information from Primary Sources List of Figures Figure 1. Global Recombinant Proteins Market Share by Type: 2020 VS 2026 Figure 2. Hormones Features Figure 3. Growth Factors Features Figure 4. Cytokines Features Figure 5. Plasma Protein Factor Features Figure 6. Recombinant Metabolic Enzymes Features Figure 7. Immune Checkpoint Regulators Features Figure 8. Others Features Figure 9. Global Recombinant Proteins Market Share by Application: 2020 VS 2026 Figure 10. Biopharmaceutical Companies Case Studies Figure 11. Academic and Research Institutes Case Studies Figure 12. Contract Research Organizations Case Studies Figure 13. Recombinant Proteins Report Years Considered Figure 14. Global Recombinant Proteins Market Size YoY Growth 2015-2026 (US$ Million) Figure 15. Global Recombinant Proteins Market Share by Regions: 2020 VS 2026 Figure 16. Global Recombinant Proteins Market Share by Regions (2021-2026) Figure 17. Porter's Five Forces Analysis Figure 18. Global Recombinant Proteins Market Share by Players in 2019 Figure 19. Global Top Recombinant Proteins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Proteins as of 2019 Figure 20. The Top 10 and 5 Players Market Share by Recombinant Proteins Revenue in 2019 Figure 21. North America Recombinant Proteins Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Europe Recombinant Proteins Market Size YoY Growth (2015-2020) (Million US$) Figure 23. China Recombinant Proteins Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Japan Recombinant Proteins Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Middle East Recombinant Proteins Market Size YoY Growth (2015-2020) (Million US$) Figure 26. India Recombinant Proteins Market Size YoY Growth (2015-2020) (Million US$) Figure 27. Central & South America Recombinant Proteins Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Abcam PLC Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Abcam PLC Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 30. R&D Systems Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. R&D Systems Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 32. Miltenyi Biotec Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Miltenyi Biotec Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 34. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 36. Sigma Aldrich Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Sigma Aldrich Company Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 38. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. GE Healthcare Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 40. Lonza Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Lonza Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 42. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Merck KGaA Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 44. ProSpec Tany TechnoGene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. ProSpec Tany TechnoGene Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 46. Eurogentec (Kaneka Corporation) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Eurogentec (Kaneka Corporation) Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 48. PeproTech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. PeproTech Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 50. BPS Bioscience Total Revenue (US$ Million): 2019 Compared with 2018 Figure 51. BPS Bioscience Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 52. Reprocell Total Revenue (US$ Million): 2019 Compared with 2018 Figure 53. Reprocell Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 54. GenScript Biotech Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 55. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 56. Abnova Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 57. Abnova Corporation Revenue Growth Rate in Recombinant Proteins Business (2015-2020) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Abcam PLC R&D Systems Miltenyi Biotec Thermo Fisher Scientific Sigma Aldrich Company GE Healthcare Lonza Merck KGaA ProSpec Tany TechnoGene Eurogentec (Kaneka Corporation) PeproTech BPS Bioscience Reprocell GenScript Biotech Corporation Abnova Corporation